Esperion Therapeutics is being taken private by ARCHIMED in a $1.1 billion deal

3 sources covered this compare →

All three outlets report the core financial terms and structure of the acquisition accurately, but differ slightly in framing. The Reuters wire story, distributed via Google News, emphasizes the transactional mechanics and timeline in…